Safety and Efficacy of Clozapine for schizophrenia
This study is completed in Japan. It is testing safety and Efficacy of Clozapine for schizophrenia.
Multiple locations, including Chiba
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Japan. It is testing safety and Efficacy of Clozapine for schizophrenia.
Multiple locations, including ChibaThis study is completed in the United States, in Belgium, and in Japan. It is testing safety and Efficacy of Intranasal Esketamine for treatment-resistant depression.
Multiple locations, including BirminghamThis study was terminated in the United States. It is testing Safety And Efficacy Of PF-04958242 for schizophrenia.
Multiple locations, including Garden GroveThis study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.
Multiple locations, including San FranciscoThis study was withdrawn. It is testing Long-Acting Oral Risperidone for schizophrenia.
Location not clearly listedThis study is completed in Canada. It focuses on OCD.
In HalifaxThis study is completed in France and in Bulgaria. It is testing Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension for Schizophrenia.
In FranceThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.
Multiple locations, including Garden GroveThis study is completed. It is testing treatment Adherence for schizophrenia.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including ArcadiaThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including New HavenThis study is completed. It is testing meridia® (Sibutramine Hydrochloride) for Eating disorders.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.